Gerresheimer (ETR:GXI) PT Set at €56.40 by JPMorgan Chase & Co.

JPMorgan Chase & Co. set a €56.40 ($65.58) price objective on Gerresheimer (ETR:GXI) in a research report report published on Thursday, September 26th, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

GXI has been the subject of a number of other reports. Hauck & Aufhaeuser set a €50.00 ($58.14) price objective on Gerresheimer and gave the stock a sell rating in a research note on Friday, July 12th. Independent Research set a €80.00 ($93.02) price objective on Gerresheimer and gave the stock a neutral rating in a research note on Monday, July 15th. Credit Suisse Group set a €87.00 ($101.16) price objective on Gerresheimer and gave the stock a buy rating in a research note on Monday, July 15th. Berenberg Bank set a €81.00 ($94.19) price target on Gerresheimer and gave the company a buy rating in a research note on Thursday, July 11th. Finally, Deutsche Bank set a €83.00 ($96.51) price target on Gerresheimer and gave the company a buy rating in a research note on Friday, July 12th. Three analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. Gerresheimer has a consensus rating of Hold and an average price target of €72.16 ($83.90).

Shares of GXI stock traded down €1.25 ($1.45) during mid-day trading on Thursday, hitting €64.35 ($74.83). The stock had a trading volume of 181,718 shares, compared to its average volume of 140,925. The company has a debt-to-equity ratio of 64.56, a current ratio of 0.85 and a quick ratio of 0.56. The firm has a market capitalization of $2.02 billion and a P/E ratio of 9.76. Gerresheimer has a 12-month low of €51.10 ($59.42) and a 12-month high of €74.80 ($86.98). The firm’s 50-day moving average is €66.93 and its two-hundred day moving average is €67.48.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Story: Options Trading – Understanding Strike Price

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.